Application Note

Particle Counting in Injectable Solutions

GettyImages-1069859094-IV-bag-intravenous

Liquid formulations, historically known as parenteral solutions, are now described as injectable solutions or injectables. They include opthalmics, ointments, I.V., vaccines, and others. Injectable solutions are packed as Large Volume Injectable (LVI) solutions, Small Volume Injectable (SVI) solutions, and dry powders requiring reconstitution as either LVI or SVI but most commonly as SVI.

USP, EP and JP have strict requirements for parenteral sterility. Requirements laid out by US (USP), European (EP), and Japanese (JP) Pharmacopoeia standards that demand that injectable solutions are effectively monitored for microcontamination, specifically nonsoluble particulates. It is important to have control over the limits of these non-soluble particles as they can prove to be deleterious to human health and also gauge how many particles can be deemed to be a safe limit.

In this paper we review counting particle specifications based on the type of injectable solution as well as the apparatus and methodologies you can use to demonstrate compliance.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online